Insulin-like Growth Factor-1 Receptor (IGF-1R) Kinase Inhibitors in Cancer Therapy: Advances and Perspectives

By  

Current Pharmaceutical Design, Vol. 18, Iss. 20, 2012-07 ,pp. : 2901-2913

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer

By Yuen John SP   Macaulay Valentine M  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 5, 2008-05 ,pp. : 589-603

Informa Healthcare

Access to resources Recommend Favorite

Recent Advancements in Small Molecule Inhibitors of Insulin–like Growth Factor-1 Receptor (IGF-1R) Tyrosine Kinase as Anticancer agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 5, 2013-04 ,pp. : 653-681

Bentham Science Publishers

Access to resources Recommend Favorite

A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study

By Pappo Alberto S.   Vassal Gilles   Crowley John J.   Bolejack Vanessa   Hogendoorn Pancras C. W.   Chugh Rashmi   Ladanyi Marc   Grippo Joseph F.   Dall Georgina   Staddon Arthur P.   Chawla Sant P.   Maki Robert G.   Araujo Dejka M.   Geoerger Birgit   Ganjoo Kristen   Marina Neyssa   Blay Jean-Yves   Schuetze Scott M.   Chow Warren A.   Helman Lee J.  

Cancer, Vol. 120, Iss. 16, 2014-08 ,pp. : 2448-2456

Blackwell Publishing

Access to resources Recommend Favorite

Targeting insulin-like growth factor-1 to treat Alzheimer's disease

By Torres-Aleman Ignacio  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 12, 2007-12 ,pp. : 1535-1542

Informa Healthcare

Access to resources Recommend Favorite